Spots Global Cancer Trial Database for sarcomas
Every month we try and update this database with for sarcomas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | NCT02568267 | Breast Cancer Cholangiocarcin... Colorectal Canc... Head and Neck N... Lymphoma, Large... Melanoma Neuroendocrine ... Non-Small Cell ... Ovarian Cancer Pancreatic Canc... Papillary Thyro... Primary Brain T... Renal Cell Carc... Sarcomas Salivary Gland ... Adult Solid Tum... | Entrectinib | 18 Years - | Hoffmann-La Roche | |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC | NCT04140526 | Non Small Cell ... Advanced Solid ... Metastatic Mela... Metastatic Head... Metastatic Rena... Metastatic Colo... Sarcomas Metastatic Pros... Ovarian Cancer Small Cell Lung... Metastatic Brea... Pancreas Cancer Gastric Cancer Esophageal Canc... Gastroesophagea... Cervical Cancer Adenoid Cystic ... Salivary Gland ... Urothelial Carc... | ONC-392 Pembrolizumab Docetaxel | 18 Years - | OncoC4, Inc. | |
| Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma | NCT01879085 | Sarcoma | Docetaxel Gemcitabine Vorinostat Pegfilgrastim | 18 Years - | University of Pittsburgh | |
| Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas | NCT02192541 | Neoplasms | Ziv-Aflibercept Ganetespib | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas | NCT00881595 | Soft Tissue Sar... | Chemoradiothera... Proton therapy Proton Chemorad... | 55 Years - | University of Florida | |
| A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer | NCT00754286 | Brain Tumors Leukemia Sarcomas Neuroblastoma Lymphoma Hodgkins Diseas... | Aromatherapy Sc... Placebo wand | 7 Years - 21 Years | Albert Einstein College of Medicine | |
| An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS) | NCT00796120 | Sarcoma | Trabectedin Doxorubicin Ifosfamide | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| An Adequate Cost Effective Follow Up Protocol For Bone and Soft Tissue Sarcomas | NCT05827458 | Sarcomas | - 65 Years | Tata Memorial Hospital | ||
| Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy | NCT01998529 | Lung Cancer | Cisplatin Amifostine | 3 Years - 21 Years | M.D. Anderson Cancer Center | |
| Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma | NCT00847366 | Non Small Cell ... Solid Tumors Metastatic Brea... Sarcomas | Perifosine Trastuzumab Tamoxifen | 18 Years - | AEterna Zentaris | |
| A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer | NCT00754286 | Brain Tumors Leukemia Sarcomas Neuroblastoma Lymphoma Hodgkins Diseas... | Aromatherapy Sc... Placebo wand | 7 Years - 21 Years | Albert Einstein College of Medicine | |
| Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy | NCT01998529 | Lung Cancer | Cisplatin Amifostine | 3 Years - 21 Years | M.D. Anderson Cancer Center | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| AMG 386 Drug-Drug Interaction Study With Paclitaxel | NCT01992341 | Advanced Solid ... | AMG 386 Paclitaxel | 18 Years - | Amgen | |
| Detection of Circulating Tumor Cells in Patients With Sarcomas | NCT02983539 | Leiomyosarcoma Pleomorphic Lip... Synovial Sarcom... Liposarcoma | 18 Years - 70 Years | AC Camargo Cancer Center | ||
| An Adequate Cost Effective Follow Up Protocol For Bone and Soft Tissue Sarcomas | NCT05827458 | Sarcomas | - 65 Years | Tata Memorial Hospital | ||
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies | NCT04648826 | Sarcomas Melanomas Germ Cell Tumor... Epithelial Mali... Pulmonary Metas... | AeroEclipse II ... Bintrafusp alfa Azacytidine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC | NCT04140526 | Non Small Cell ... Advanced Solid ... Metastatic Mela... Metastatic Head... Metastatic Rena... Metastatic Colo... Sarcomas Metastatic Pros... Ovarian Cancer Small Cell Lung... Metastatic Brea... Pancreas Cancer Gastric Cancer Esophageal Canc... Gastroesophagea... Cervical Cancer Adenoid Cystic ... Salivary Gland ... Urothelial Carc... | ONC-392 Pembrolizumab Docetaxel | 18 Years - | OncoC4, Inc. | |
| Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma | NCT05734066 | Refractory Ewin... Relapsed Ewing ... Ewing Sarcoma | Lurbinectedin | 2 Years - 30 Years | Jazz Pharmaceuticals | |
| Blood and Tissue Study of Patients in NIH Protocol 08-C-0800 | NCT00923325 | Sarcomas | 2 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas | NCT00881595 | Soft Tissue Sar... | Chemoradiothera... Proton therapy Proton Chemorad... | 55 Years - | University of Florida | |
| Dendritic Cell Vaccination for Patients With Solid Tumors | NCT01291420 | Glioblastoma Renal Cell Carc... Sarcomas Breast Cancers Malignant Mesot... Colorectal Tumo... | autologous dend... | 18 Years - | University Hospital, Antwerp | |
| Detection of Circulating Tumor Cells in Patients With Sarcomas | NCT02983539 | Leiomyosarcoma Pleomorphic Lip... Synovial Sarcom... Liposarcoma | 18 Years - 70 Years | AC Camargo Cancer Center | ||
| Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas | NCT02192541 | Neoplasms | Ziv-Aflibercept Ganetespib | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Blood and Tissue Study of Patients in NIH Protocol 08-C-0800 | NCT00923325 | Sarcomas | 2 Years - 99 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
